HEALTHCARE

Market Highlights: Rhabdomyosarcoma is anticipated to grow at a CAGR of 4.8%. Rhabdomyosarcoma or RMS is a type of soft tissue cancer. It is rare cancer and affects the skeletal muscle tissue. Sometimes, it also affects the hollow organs like uterus or bladder. RMS can affect people of any age, but it mostly affects children. The increasing prevalence of rhabdomyosarcoma, rising research & development expenditure and useful molecules in the pipeline are expected to drive the growth of the market during the forecast period. Additionally, the increasing awareness among people is likely to boost the market growth. On the other hand, high treatment costs, side effects of the treatment, improper results of the drugs in the pipeline and strict government regulations may hinder the growth of the market during the forecast period. The global Rhabdomyosarcoma Market Insights is currently dominated by many market players. The key players in the market are engaging themselves in new pro...

Market Overview: Periodontal continues to be one of the major causes of tooth loss and a major oral health issue. The disease is common in both developed and developing countries, affecting nearly 20 to 50% of the global population. Over the years, different periodontal therapies have come up with a high degree of effectivity. Both surgical and non-surgical treatment options available. Global Periodontal Therapeutic Market Insights set to witness a strong growth in the forthcoming years. The latest study conducted by Market Research Future (MRFR) reveals that the global periodontal therapeutic market will surge at 9.2% CAGR during 2018 to 2023 .   The onset of periodontal issues could be triggered by poor oral hygiene, diabetes mellitus, stress, smoking and hormonal changes in females. The incidence rate has continued to grow, which is also driving the demand for periodontal therapeutic. As per World Health Organization (WHO), there is a high incident rate of gingival b...

Market Highlights: The global neuroblastoma is anticipated to hold a market value of 2.60 billion in 2017 and is expected to grow at a CAGR of 3.7% during the forecast period. Neuroblastoma is a childhood cancer most commonly occurs in children below the age of 5 years. The neuroblast may cause due to the immature cell growth or mutation in the gene responsible for controlling cell proliferation. The increasing cases of childhood cancer, rising research on neuroblastoma treatment and increasing spending on cancer treatment is expected to drive market growth over the forecast period. According to the American Society of Clinical Oncology (ASCO) April 2018 publication, every year, more than 700 children get diagnosed with neuroblastoma in the US and it is also indicated that neuroblastoma is the most common cancer in children younger than 1 year. It is more commonly found in boys compare to girls. The increasing cases of childhood cancer boost market growth during the forecast period. ...

Market Overview: The global beauty devices market had always been an ever-increasing space. Surprisingly, the market is continuously growing during the imposed lockdown to control the spread of coronavirus pandemic. Industry experts say that beauty products are witnessing this unexpected increase in sales as people like to look their best on video calls and behind masks. Also, the home-use beauty devices market is experiencing booming sales worldwide, especially in the American regions. In Japan, although the economic growth is plunged into recession in the first quarter due to the coronavirus pandemic, the sale of beauty products in departmental stores are rising at a record rate. And even if, squelched production and exports are expected to grow worse with times, industry players are gearing up for the boost, reading the signs of recovery from consumers. They are setting up strategies and action plans to gain a larger competitive share during the COVID-19 crisis. Market Research ...

Market Overview: Throat-lozenges are the most preferred go-to solution for sore throat. Not only are the easily accessible but also cost-effective, which makes them the preferred choice of medication among patients. The global  Throat Lozenges Market  is anticipated to reach USD 6588.72 Mn at a CAGR of 4.20% over the forecast period of 2018-2023. The global  Covid 19 Analysis on Throat Lozenges Market  is driven by the towering prevalence of common cold and flu across the globe. Common cough and cold tend to occur all year round and are contagious in nature due to which they keep on spreading. Due to the inherent trend of resorting to over-the-counter medications, throat lozenges are predominantly the first line of treatment in case of throat infections. These lozenges are available in different flavors, and new flavors are being introduced continually, which has increased adoption among consumers. In addition, throat lozenges can be purchased and consumed wi...

Market Overview: The prevalence of prostate disorders has become widespread, and Market Research Future (MRFR) perceives the growth of the global Prostate Laser Surgery Industry Dynamics to be healthy at a CAGR of 7.2% over the forecast period of 2017-2023. Spiraling incidences of urology disorders such as benign prostatic hyperplasia (BPH) or enlargement of the prostate induces high demand for prostate laser surgery. Such disorders are more common among the geriatric population. Rising geriatric population across the globe is a prime factor in shaping the growth of the global prostate laser surgery market. A growing preference for minimally invasive surgical procedures is a significant factor in driving the growth of the global prostate laser surgery market. Laser surgery is associated with benefits such as speedy relief, minimal blood loss, and reduced post-operative complications. Get a Free Sample @ https://www.marketresearchfuture.com/sample_request/5108 Other ...

Market Overview: The rise in a number of FDA approvals complement such innovations and augment the growth of the global deformity market. As an add-on, governments and non-profit organizations are also showing interest in spreading awareness regarding the disease and are actively providing support for R&D activities. This can also play a driving factor in the advancement of the global deformity market. There is no particular treatment available for deformity due to which the costs associated with surgery and treatment is very high which can hamper the growth of the global deformity market. The Physicians Committee reports that approximately 3% of all children born in the U.S. suffer major malformations at birth. In addition , each year, over 150000 babies are born with congenital disabilities . High healthcare spends on a global scale has been pivotal in shaping the global deformity market. With better medical facilities purveyed by the development of imaging techno...